{
    "Title": "WR279,396, a Third Generation Aminoglycoside Ointment for the Treatment of Leishmania major Cutaneous Leishmaniasis: A Phase 2, Randomized, Double Blind, Placebo Controlled Study",
    "URL": "https://doi.org/10.1371/journal.pntd.0000432",
    "Published": "May 5, 2009",
    "Subject_Areas": [
        "Lesions",
        "Leishmaniasis",
        "Erythema",
        "Drug therapy",
        "Pain",
        "Phase II clinical investigation",
        "Leishmania",
        "Toxicity"
    ],
    "Authors": {
        "Afif Ben Salah": [
            "Institut Pasteur de Tunis, Tunis, Tunisia"
        ],
        "Pierre A. Buffet": [
            "Institut Pasteur, Paris, France"
        ],
        "Gloria Morizot": [
            "Institut Pasteur, Paris, France"
        ],
        "Nathalie Ben Massoud": [
            "Institut Pasteur de Tunis, Tunis, Tunisia"
        ],
        "Amor Zâatour": [
            "Institut Pasteur de Tunis, Tunis, Tunisia"
        ],
        "Nissaf Ben Alaya": [
            "Institut Pasteur de Tunis, Tunis, Tunisia"
        ],
        "Nabil Bel Haj Hamida": [
            "Institut Pasteur de Tunis, Tunis, Tunisia"
        ],
        "Zaher El Ahmadi": [
            "Direction Régionale de la Santé de Sidi Bouzid, Sidi Bouzid, Tunisia"
        ],
        "Matthew T. Downs": [
            "Statistics Collaborative, Washington, D.C., United States of America"
        ],
        "Philip L. Smith": [
            "United States Army Medical Materiel Development Activity, Fort Detrick, Maryland, United States of America"
        ],
        "Koussay Dellagi": [
            "Institut Pasteur de Tunis, Tunis, Tunisia"
        ],
        "Max Grögl": [
            "Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America"
        ]
    }
}